Media Kit

Scroll to top of page

Featured News

Announcement
Neurology
Parkinson's Disease

BlueRock Therapeutics receives FDA Regenerative Medicine Advanced Therapy designation for Parkinson’s disease cell therapy candidate bemdaneprocel

BlueRock Logo and Foundation Fighting Blindness Logo
Announcement
Ophthalmology

BlueRock Therapeutics and Foundation Fighting Blindness announce collaboration to expand the Uni-Rare natural history study of patients living with inherited retinal diseases

Announcement
Neurology
Parkinson's Disease

BlueRock Therapeutics phase I clinical trial for Parkinson’s disease continues to show positive trends at 18 months

multicolor title graphic for cell & gene the podcast featuring BlueRock Therapeutics
Podcast

Cell & Gene The Podcast | Inside BlueRock Therapeutics' Parkinson's Disease Trial

See All

Media Library

Media Contact

Video

B-Roll: Lab 1

B-Roll: Lab 2

B-Roll: Lab 3

B-Roll: Lab 4

B-Roll: Lab 5

B-Roll: Lab 6

B-Roll: PSC-Derived Cardiomyocytes

Explore more with BlueRock

Cell Therapy

Our Programs

Our Pipeline

Careers